H1

Healthcare data analytics and research solutions

New York City, New York, United States

About H1

H1.co operates in the healthcare technology sector, focusing on connecting healthcare professionals with research and insights. The company provides data-driven solutions that help clients, including healthcare professionals, life sciences companies, payors, and patients, make informed decisions. H1.co's products utilize healthcare data to offer insights for various applications such as clinical trial design and market access. Unlike many competitors, H1.co emphasizes the democratization of healthcare data and offers a free platform, H1 Connect, for accessing expert insights. The company's goal is to enhance the efficiency of healthcare delivery and research by providing accurate and comprehensive data.

New York City, New YorkHeadquarters
2017Year Founded
$181.9MTotal Funding
SERIES_CCompany Stage
Data & Analytics, Biotechnology, HealthcareIndustries
201-500Employees

Risks

Integration of Ribbon Health may lead to data inconsistencies.
AI-driven platforms like GenosAI Pro risk biases in trial designs.
Global expansion through H1 Connect may face regulatory hurdles.

Differentiation

H1 offers a comprehensive healthcare platform connecting diverse stakeholders in real-time.
The company provides AI-enabled data analytics for strategic insights in life sciences.
H1's Trial Landscape platform enhances clinical trial diversity and efficiency.

Upsides

H1's acquisition of Ribbon Health strengthens its data management capabilities.
The partnership with CTI advances diversity and efficiency in clinical trials.
H1's inclusion in the New York Digital Health 100 highlights its innovation.